KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Long-Term Investments (2020 - 2025)

Oscar Health (OSCR) has disclosed Long-Term Investments for 6 consecutive years, with $2.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments rose 48.05% year-over-year to $2.7 billion, compared with a TTM value of $2.7 billion through Dec 2025, up 48.05%, and an annual FY2025 reading of $2.7 billion, up 48.05% over the prior year.
  • Long-Term Investments was $2.7 billion for Q4 2025 at Oscar Health, up from $2.6 billion in the prior quarter.
  • Across five years, Long-Term Investments topped out at $2.7 billion in Q4 2025 and bottomed at $26.4 million in Q1 2021.
  • Average Long-Term Investments over 5 years is $843.8 million, with a median of $433.7 million recorded in 2022.
  • The sharpest move saw Long-Term Investments crashed 96.72% in 2022, then surged 8701.79% in 2025.
  • Year by year, Long-Term Investments stood at $844.5 million in 2021, then tumbled by 73.6% to $222.9 million in 2022, then skyrocketed by 63.88% to $365.3 million in 2023, then soared by 396.91% to $1.8 billion in 2024, then surged by 48.05% to $2.7 billion in 2025.
  • Business Quant data shows Long-Term Investments for OSCR at $2.7 billion in Q4 2025, $2.6 billion in Q3 2025, and $1.8 billion in Q2 2025.